Next: Cancer software - Oregon Business
Links shared publicly online about this topic.
- 938total visits
Next: Cancer software - Oregon Business
View full resource at oregonbusiness.com
Tags: Cancer, Breast Cancer, Imaging Tests, Magnetic Resonance Imaging, Women's Health, Senior Health, Scientist, Science
Most Recently Shared on August 18, 2010 at 6:09 pm By:
135 patients, 100% accuracy. So cool. RT @OregonBusiness: Scientist at @OHSUHealthcare improves cancer testing accuracy http://bit.ly/91TllD
Roche to offer discounted cancer drugs in India | Business | The Guardian
guardian.co.uk — “Swiss pharmaceutical company to offer sharply discounted versions of two cancer drugs in India from next year” View full resource at guardian.co.uk
Most Recently Shared on March 23, 2012 at 1:32 pm By:
Guardian Science Science Enthusiast
Roche to offer discounted cancer drugs in India http://t.co/84tDShl6
From social intranets to collaboration ecosystems - Forbes | Rise of social business in healthcare | Scoop.it
scoop.it — “Social intranet is a hot topic. With the rise of social software, the next step to the enterprise social nirvana is the intranet.” View full resource at scoop.it
Most Recently Shared on December 2, 2011 at 8:12 pm By:
RT @jbselz: From Social Intranets to Collaboration Ecosystems by @FredCavazza http://t.co/nEx7aytb #hcsm #HITsm #epharma #hcsmeu
IBM Unveils Analytics For Communications, Healthcare - Software - Business Intelligence - Informationweek
informationweek.com — “Big Blue sees Big Data as the next frontier for its software and services businesses.” View full resource at informationweek.com
Most Recently Shared on October 27, 2011 at 1:23 pm By:
IBM Healthcare Health Business
IBM Unveils Analytics For Communications, Healthcare: http://t.co/S1ihs37v
GE Healthcare to Invest $1 Billion in Oncology - Pharmaceutical Technology
pharmtech.findpharma.com — “GE Healthcare, the health business of General Electric, will dedicate $1 billion of its total R&D budget during the next five years to its technologies for manufacturing biopharmaceuticals and for cancer research. Part of the money will go toward expanding the company's cancer-diagnostic and molecular-imaging capabilities, as well.” View full resource at pharmtech.findpharma.com
Most Recently Shared on September 22, 2011 at 5:00 pm By:
GE Healthcare to Invest $1 Billion in Oncology http://t.co/6xOclWQJ
Prostate Cancer Prognostic Marker Discovery By Next Generation Sequencing - Topix
topix.com — “Prostate Cancer Prognostic Marker Discovery By Next Generation Sequencing - Topix” View full resource at topix.com
Most Recently Shared on August 24, 2011 at 1:57 pm By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
Prostate Cancer Prognostic Marker Discovery By Next Generation Sequencing: Genomatix Software, the Uniformed Ser... http://t.co/BHemEBX
Prostate Cancer Prognostic Marker Discovery By Next Generation Sequencing
medicalnewstoday.com — “Genomatix Software, the Uniformed Service University of the Health Sciences (USU), and the Henry M. Jackson Foundation (HJF) for the Advancement of Military Medicine, Inc. have entered into a Coop” View full resource at medicalnewstoday.com
Most Recently Shared on August 24, 2011 at 8:06 am By:
john clay mchugh Urologist, Physician, Doctor, and Surgeon
Prostate Cancer Prognostic Marker Discovery By Next Generation Sequencing: Genomatix Software, the Uniformed Ser... http://t.co/yPVgbZb
Prostate Cancer Prognostic Marker Discovery By Next Generation Sequencing
medicalnewstoday.com — “Genomatix Software, the Uniformed Service University of the Health Sciences (USU), and the Henry M. Jackson Foundation (HJF) for the Advancement of Military Medicine, Inc. have entered into a Coop” View full resource at medicalnewstoday.com
Most Recently Shared on August 24, 2011 at 7:05 am By:
Prostate Cancer Prognostic Marker Discovery By Next Generation Sequencing http://mnt.to/3Z87 #prostate
Life Technologies launches new genomic analysis software
news-medical.net — “Addressing the issue of data overload from next-generation sequencers, Life Technologies Corporation today launched its LifeScope 2.0 Genomic Analysis Software, a significantly enhanced bioinformatics system for analyzing data from genomic sequencing instruments to study human disease such as cancer.” View full resource at news-medical.net
Most Recently Shared on May 27, 2011 at 1:30 pm By:
Genetics News: Life Technologies launches new genomic analysis software: Addressing the issue of data overload f... http://bit.ly/k9pvMN
NewGene: New Genetics Test for Hereditary Breast Cancer Cuts Costs and Turnaround Times | Business Wire
businesswire.com — “New Genetics Test for Hereditary Breast Cancer Cuts Costs and Turnaround Times” View full resource at businesswire.com
Most Recently Shared on May 20, 2011 at 1:16 am By:
Matt Mealiffe, M.D. Internist, Physician, Geneticist, and Doctor
RT @BRCAscoop: More on NewGene Next Generation Sequencing-Based BRCA1 and BRCA2 test in Europe - http://bit.ly/lXZmxk
Merge Healthcare part of "virtual" lab for cancer trial - FierceBiotechIT
fiercebiotechit.com — “Merge Healthcare ($MRGE) is gaining more traction in its clinical software business. The Chicago-based company says that its clinical image management software will be used in an upcoming trial Read more...” View full resource at fiercebiotechit.com
Most Recently Shared on May 9, 2011 at 12:49 pm By:
Merge Healthcare part of "virtual" lab for cancer trial. http://bit.ly/lWPHgh
Next-gen nanoparticle can image, deliver, heat and destroy - FierceDrugDelivery
fiercedrugdelivery.com — “At Canada's Ontario Cancer Institute, they're busy building a better nanomaterial for drug delivery. Or, rather, busy enabling the new material to assemble itself. They're called porphysomes, and Read more >>” View full resource at fiercedrugdelivery.com
Most Recently Shared on March 30, 2011 at 12:58 pm By:
Next-gen nanoparticle can image, deliver, heat and destroy. http://bit.ly/i0XHbY
Proteomics Research Heading Towards Personalized Treatments For Cancer, Diabetes And Inflammatory Diseases - QualityPoint Technologies
qualitypointtech.net — “NeoProteomics Inc., a biomarker development and software company, has secured an exclusive option agreement with Case Western Reserve University. The deal has potential to enhance various forms of treatment of cancer, diabetes, and inflammatory diseases. Proteomics is the scientific next step in vital research of protein structures of biological systems. NeoProteomics, founded in 2006 in Cleveland near Case Western Reserve's School of Medicine, focuses on biomarker identification and validation ” View full resource at qualitypointtech.net
Most Recently Shared on March 27, 2011 at 12:35 pm By:
Proteomics Research Heading Towards Personalized Treatments For Cancer, Diabetes And Inflammatory Diseases: NeoPro... http://bit.ly/gWnIsG
MARROW MYTHS 1/24/2011 - Stupid Cancer Show | Internet Radio | Blog Talk Radio
blogtalkradio.com — “SURVIVOR SPOTLIGHT LINDSAY RAWOT Young Adult Survivor Non-Hodgkins Lymphoma ADVOCATE SPOTLIGHT AMANDA ZWILLING Young Adult Cancer Advocate KATHARINA HARF COO and Co-founder DKMS Americas ALINA SUPRUNOVA Business Development DKMS Americas EMILY PETERSON Senior Resource Development Specialist Office of Patient Advocacy National Marrow Donor Program MARY HALET Regional Director Recruitment/Community Development National Marrow Donor Program Jan 24 2011” View full resource at blogtalkradio.com
Most Recently Shared on January 19, 2011 at 2:16 pm By:
Matthew Zachary Patient Expert
"Marrow Myths" on next Mon's @StupidCancer Show w/special guests @DKMSAmericas & Nat'l Marrow Donor Prog @BeThemMatch http://bit.ly/gc1Hme
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer | Business Wire
businesswire.com — “BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced today that a P” View full resource at businesswire.com
Most Recently Shared on December 10, 2010 at 9:32 am By:
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer: WOBURN, Mass.--(BUSINESS WIRE)--BioVex Inc... http://bit.ly/fdRxWe
Tools measure impact of cancer drugs - Business - NZ Herald News
nzherald.co.nz — “The next breakthrough in cancer treatment drugs could be helped by Timaru biotechnology company Symansis.” View full resource at nzherald.co.nz
Most Recently Shared on November 17, 2010 at 8:17 pm By:
Drugs and Devices OW OW Health
Tools measure impact of cancer drugs: The next breakthrough in cancer treatment drugs could be helped by Timaru ... http://bit.ly/bc4WJw
Advertisement
